Nearly two months after sending out press releases that crowed about the company’s advancements, Numinus Wellness Inc. (OTC: NUMIF) walked back those claims and blamed its...
The Ninth Circuit will weigh whether “right-to-try” laws allow patients to access psychedelic substances. The Ninth Circuit Court of Appeals is set to hear arguments in...
The U.S. Food and Drug Administration warned consumers that certain mushroom-containing chocolate bars have been linked to illnesses in eight people across four states. In an...
The Institute for Clinical and Economic Review (ICER) recently posted its revised evidence report assessing the comparative clinical effectiveness and value of 3,4-Methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP, a...
A panel of independent health advisers convened Tuesday to consider a landmark proposal to approve MDMA as a treatment for post-traumatic stress disorder. In the end,...
The U.S. Government Accountability Office (GAO) told the Drug Enforcement Administration (DEA) that it needs to do a better job with religious exemption requests it gets...
Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) announced Health Canada and the United States Food and Drug Administration (FDA) authorization for a Phase 2 clinical...
The judge quoted a South Park movie song Blame Canada in his opinion. FSD Pharma Inc. (NASDAQ: HUGE)(CSE: HUGE) won its battle with the company’s former...
Author: C. Adam Foster, Esq. Source link
A newly published study from researchers at New York University found that individuals dealing with a stutter derived some benefit from substances such as psilocybin, the...